LifeTrac was founded in 1988 to offer solutions that focus on high-cost, low-frequency medical events. In 2020, Emerging Therapy Solutions acquired LifeTrac. Emerging Therapy Solutions was originally founded in 2018 to offer expert services to help payers and other risk-bearing entities prepare for the accelerating growth in cell and gene therapy. The LifeTrac team brings over 30 years of experience in bone marrow and solid organ transplants, plus provider relationships and agreements, to complement Emerging Therapy Solutions’ expertise in cell and gene therapies. The integrated company became Emerging Therapy Solutions (ETS) in 2021.